Literature DB >> 17698985

Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.

Jonathan D Roth1, Heather Hughes, Todd Coffey, Holly Maier, James L Trevaskis, Christen M Anderson.   

Abstract

Amylin infusion reduces food intake and slows body weight gain in rodents. In obese male rats, amylin (but not pair feeding) caused a preferential reduction of fat mass with protein preservation despite equal body weight loss in amylin-treated (fed ad libitum) and pair-fed rats. In the present study, the effect of prior or concurrent food restriction on the ability of amylin to cause weight loss was evaluated. Retired female breeder rats were maintained on a high-fat diet (40% fat) for 9 wk. Prior to drug treatment, rats were either fed ad libitum or food restricted for 10 days to lose 5% of their starting body weight. They were then subdivided into treatment groups that received either vehicle or amylin (100 microgxkg(-1)xday(-1) via subcutaneous minipump) and placed under either a restricted or ad libitum feeding schedule (for a total of 8 treatment arms). Amylin 1) significantly reduced body weight compared with vehicle under all treatment conditions, except in always restricted animals, 2) significantly decreased percent body fat in all groups, and 3) preserved lean mass in all groups. These results indicate that amylin's anorexigenic and fat-specific weight loss properties can be extended to a variety of nutritive states in female rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698985     DOI: 10.1152/ajpendo.00395.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  5 in total

1.  Modeling energy intake and body weight effects of a long-acting amylin analogue.

Authors:  Annika Brings; Jens Markus Borghardt; Jolanta Skarbaliene; Tamara Baader-Pagler; Maria A Deryabina; Wolfgang Rist; Stefan Scheuerer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-23       Impact factor: 2.745

2.  A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.

Authors:  Sofie Gydesen; Sara Toftegaard Hjuler; Zenia Freving; Kim Vietz Andreassen; Nina Sonne; Lars I Hellgren; Morten Asser Karsdal; Kim Henriksen
Journal:  Br J Pharmacol       Date:  2017-02-15       Impact factor: 8.739

3.  Central amylin acts as an adiposity signal to control body weight and energy expenditure.

Authors:  Peter Y Wielinga; Christian Löwenstein; Sabine Muff; Manuela Munz; Stephen C Woods; Thomas A Lutz
Journal:  Physiol Behav       Date:  2010-04-21

4.  Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity.

Authors:  Ambrose A Dunn-Meynell; Christelle Le Foll; Miranda D Johnson; Thomas A Lutz; Matthew R Hayes; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-16       Impact factor: 3.619

5.  Amylin/leptin synergy is absent in extreme obesity and not restored by calorie restriction-induced weight loss in rats.

Authors:  J L Trevaskis; C Wittmer; J Athanacio; P S Griffin; D G Parkes; J D Roth
Journal:  Obes Sci Pract       Date:  2016-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.